uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 6, 2015

Seller of Aloe Supplement Warned for Drug Claims

On January 21, 2015, the FDA issued a warning letter to Pristine Nutraceuticals, LLC, following a review of the company's website,, which found statements made about DigestaCure to be drug claims.

DigestaCure contains long-chain polymannan and polysaccharide molecules, mannose molecules, glucomannans, glucopolymannans, medium and short chain polysaccharides, mucopolysaccharides, glycoproteins and glycolipids derived from aloe.

It was promoted to treat a variety of autoimmune and other conditions, with statements such as "If you suffer from an Autoimmune Condition, we have your Solution," and "Each capsule of DigestaCure contains 500mg of pure, concentrated immune modulating components, for the restoration of immunity and elimination of autoimmunity."

The company's website also links to a second website which promoted the supplement with customer testimonials such as "I have used your product and no longer have celiac disease" and "The product has healed me of Crohn's disease."

See the Aloe Supplements Review for tests of related products.

See Related Warnings:

CVS Sued for Eye Health Supplement Claims

Seller of Aloe, Sexual Enhancement Supplements and More Warned for Manufacturing Violations, Drug Claims

Seller of "Ebola" Supplement Warned for Drug Claims

Seller of Silver Supplement Warned for Claiming to Treat Ebola and Other Viruses

FDA Warns Seller of Supplements and Chocolate Promoted to Treat Ebola

Sellers of Essential Oils Warned for Claiming to Treat Ebola, Other Diseases

To read the FDA's warning letter, use the link below.